Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 4, 2008, Pages 1199-1204

  Teng, Felicia Yu Hsuan ^a   Tang, Bor Luen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Amyotrophic lateral sclerosis; Nogo; Nogo 66 receptor; p75NTR

Indexed keywords

ISOPROTEIN; MYELIN PROTEIN; NERVE GROWTH FACTOR RECEPTOR; PROTEIN NOGO;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; CELL DEATH; CYTOLOGY; HUMAN; METABOLISM; MOTONEURON; PATHOLOGY; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; HUMANS; MOTOR NEURONS; MYELIN PROTEINS; PROTEIN ISOFORMS; RECEPTOR, NERVE GROWTH FACTOR;

MUS;

EID: 49549113645     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00351.x     Document Type: Review

References (76)

1. Chen MS, Huber AB, Van Der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000 : 403 : 434 9.
2. Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G, Michalovich D, Simmons DL, Walsh FS. Inhibitor of neurite outgrowth in humans. Nature. 2000 : 403 : 383 4.
3. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature. 2000 : 403 : 439 44.
4. Lee DH, Strittmatter SM, Sah DW. Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov. 2003 : 2 : 872 8.
5. He Z, Koprivica V. The Nogo signaling pathway for regeneration block. Annu Rev Neurosci. 2004 : 27 : 341 68.
6. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol. 2004 : 14 : 118 24.
7. Huber AB, Weinmann O, Brösamle C, Oertle T, Schwab ME. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci. 2002 : 22 : 3553 67.
8. Oertle T, Klinger M, Stuermer CA, Schwab ME. A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J. 2003 : 17 : 1238 47.
9. Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001 : 409 : 341 6.
10. Oertle T, Van Der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, Huber AB, Simonen M, Schnell L, Brösamle C, Kaupmann K, Vallon R, Schwab ME. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci. 2003 : 23 : 5393 406.
11. Liu BP, Fournier A, GrandPré T, Strittmatter SM. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 2002 : 297 : 1190 3.
12. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002 : 417 : 941 4.
13. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z. Filbin M. Myelin-associated glycoprotein interacts with the Nogo-66 receptor to inhibit neurite outgrowth. Neuron. 2002 : 35 : 283 90.
14. Hu F, Liu B P, Budel S, Liao J, Chin J, Fournier A, Strittmatter SM. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J Neurosci. 2005 : 25 : 5298 304.
15. Hu F, Strittmatter SM. The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci. 2008 : 28 : 1262 9.
16. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, Fulton D, Tempst P, Strittmatter SM, Sessa WC. A new role for Nogo as a regulator of vascular remodeling. Nat Med. 2004 : 10 : 382 8.
17. Miao RQ, Gao Y, Harrison KD, Prendergast J, Acevedo LM, Yu J, Hu F, Strittmatter SM, Sessa WC. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci USA. 2006 : 103 : 10997 1002.
18. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 2002 : 420 : 74 8.
19. NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci. 2002 : 5 : 1302 8.
20. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, Thill G, Levesque M, Sah D, McCoy JM, Murray B, Jung V, Pepinsky RB, Mi S. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron. 2005 : 45 : 353 9.
21. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, Garcia KC, He Z. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron. 2005 : 45 : 345 51.
22. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci. 2004 : 7 : 221 8.
23. Teng FY, Tang BL. Nogo signaling and non-physical injury-induced nervous system pathology. J Neurosci Res. 2005 : 79 : 273 8.
24. Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, Murray BM, Barres B, Tessier-Lavigne M, Bernard CC. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci. 2004 : 7 : 736 44.
25. Satoh J, Onoue H, Arima K, Yamamura T. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol. 2005 : 64 : 129 38.
26. Jurewicz A, Matysiak M, Raine CS, Selmaj K. Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis. Neurology. 2007 : 68 : 283 7.
27. Kuhlmann T, Remington L, Maruschak B, Owens T, Brück W. Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol. 2007 : 66 : 238 46.
28. Onoue H, Satoh JI, Ogawa M, Tabunoki H, Yamamura T. Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls. Acta Neurol Scand. 2007 : 115 : 153 60.
29. Bandtlow CE, Dlaska M, Pirker S, Czech T, Baumgartner C, Sperk G. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur J Neurosci. 2004 : 20 : 195 206.
30. Novak G, Kim D, Seeman P, Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res. 2002 : 107 : 183 9.
31. Novak G, Tallerico T. Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3′-UTR. Brain Res. 2006 : 1120 : 161 71.
32. Covault J, Lee J, Jensen K, Kranzler H. Nogo 3′-untranslated region CAA insertion: failure to replicate association with schizophrenia and demonstration of marked population difference in frequency of the insertion. Brain Res. 2004 : 120 : 197 200.
33. Sinibaldi L, De Luca A, Bellacchio E, Conti E, Pasini A, Paloscia C, Spalletta G, Caltagirone C, Pizzuti A, Dallapiccola B. Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum Mutat. 2004 : 24 : 534 5.
34. Meng J, Shi Y, Zhao X, Guo S, Wang H, Zheng Y, Tang R, Feng G, Gu N, Liu H, Zhu S, He L. No association between the genetic polymorphisms in the RTN4R gene and schizophrenia in the Chinese population. J Neural Transm. 2007 : 114 : 249 54.
35. He W, Lu Y, Qahwash I, Hu XY, Chang A, Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat Med. 2004 : 10 : 959 65.
36. Murayama KS, Kametani F, Saito S, Kume H, Akiyama H, Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein. Eur J Neurosci. 2006 : 24 : 1237 44.
37. Wojcik S, Engel WK, Yan R, McFerrin J, Askanas V. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers. Acta Neuropathol. 2007 : 114 : 517 26.
38. Park JH, Gimbel DA, GrandPre T, Lee JK, Kim JE, Li W, Lee DH, Strittmatter SM. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci. 2006 : 26 : 1386 95.
39. Park JH, Widi GA, Gimbel DA, Harel NY, Lee DH, Strittmatter SM. Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci. 2006 : 26 : 13279 86.
40. Gil V, Nicolas O, Mingorance A, Ureña JM, Tang BL, Hirata T, Sáez-Valero J, Ferrer I, Soriano E, del Río JA. Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease. J Neuropathol Exp Neurol. 2006 : 65 : 433 44.
41. Zhu HY, Guo HF, Hou HL, Liu YJ, Sheng SL, Zhou JN. Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease. Hum Pathol. 2007 : 38 : 426 34.
42. Strong MJ. Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy. Expert Opin Investig Drugs. 2004 : 13 : 1593 614.
43. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006 : 7 : 710 23.
44. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van Den Bergh R, Hung W, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 : 362 : 59 62.
45. Kabashi E, Valdmanis PN, Dion P, Rouleau GA. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann Neurol. 2007 : 62 : 553 9.
46. Dupuis L, Gonzalez de Aguilar JL, di Scala F, Rene F, de Tapia M, Pradat PF, Lacomblez L, Seihlan D, Prinjha R, Walsh FS, Meininger V, Loeffler JP. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis. 2002 : 10 : 358 65.
47. Dengler R, von Neuhoff N, Bufler J, Krampfl K, Peschel T, Grosskreutz J. Amyotrophic lateral sclerosis: new developments in diagnostic markers. Neurodegener Dis. 2005 : 2 : 177 84.
48. Fergani A, Dupuis L, Jokic N, Larmet Y, de Tapia M, Rene F, Loeffler JP, Gonzalez de Aguilar JL. Reticulons as markers of neurological diseases: focus on amyotrophic lateral sclerosis. Neurodegener Dis. 2005 : 2 : 185 94.
49. Pradat PF, Bruneteau G, Gonzalez de Aguilar JL, Dupuis L, Jokic N, Salachas F, Le Forestier N, Echaniz-Laguna A, Dubourg O, Hauw JJ, Tranchant C, Loeffler JP, Meininger V. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann Neurol. 2007 : 62 : 15 20.
50. Wojcik S, Engel WK, Askanas V. Increased expression of Nogo-A in ALS muscle biopsies is not unique for this disease. Acta Myol. 2006 : 25 : 116 8.
51. Askanas V, Wojcik S, Engel WK. Expression of Nogo-A in human muscle fibers is not specific for amyotrophic lateral sclerosis. Ann Neurol. 2007 : 62 : 676 7.
52. Jokic N, Gonzalez de Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, Muller A, Dubourg O, Seilhean D, Hauw JJ, Loeffler JP, Meininger V. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol. 2005 : 57 : 553 6.
53. Jokic N, Gonzalez de Aguilar JL, Dimou L, Lin S, Fergani A, Ruegg MA, Schwab ME, Dupuis L, Loeffler J P. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep. 2006 : 7 : 1162 7.
54. Harel NY, Strittmatter SM. Nogo-A marks motor neuron disease. Ann Neurol. 2007 : 62 : 1 2.
55. Dupuis L, Pehar M, Cassina P, Rene F, Castellanos R, Rouaux C, Gandelman M, Dimou L, Schwab ME, Loeffler JP, Barbeito L, Gonzalez de Aguilar JL. Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci USA. 2008 : 105 : 740 5.
56. Magnusson C, Libelius R, Tågerud S. Nogo (reticulon 4) expression in innervated and denervated mouse skeletal muscle. Mol Cell Neurosci. 2003 : 22 : 298 307.
57. Tågerud S, Libelius R, Magnusson C. Muscle Nogo-A: a marker for amyotrophic lateral sclerosis or for denervation? Ann Neurol. 2007 : 62 : 676.
58. Kim JE, Li S, GrandPré T, Qiu D, Strittmatter SM. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron. 2003 : 38 : 187 99.
59. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, Sansig G, van der Putten H, Schwab ME. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron. 2003 : 38 : 201 11.
60. Zheng B, Ho C, Li S, Keirstead H, Steward O, Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron. 2003 : 38 : 213 24.
61. Aloy EM, Weinmann O, Pot C, Kasper H, Dodd DA, Rülicke T, Rossi F, Schwab ME. Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol. 2006 : 35 : 137 56.
62. Mehta NR, Lopez PH, Vyas AA, Schnaar RL. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem. 2007 : 282 : 27875 86.
63. Venkatesh K, Chivatakarn O, Sheu SS, Giger RJ. Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition. J Cell Biol. 2007 : 177 : 393 9.
64. GrandPré T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 2002 : 417 : 547 51.
65. Gentry JJ, Barker PA, Carter BD. The p75 neurotrophin receptor: multiple interactors and numerous functions. Prog Brain Res. 2004 : 146 : 25 39.
66. Bandtlow C, Dechant G. From cell death to neuronal regeneration, effects of the p75 neurotrophin receptor depend on interactions with partner subunits. Sci STKE. 2004 : pe24.
67. NTR - live or let die. Curr Opin Neurobiol. 2005 : 15 : 49 57.
68. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Jacobsen C, Kliemannel M, Schwarz E, Willnow TE, Hempstead BL, Petersen CM. Sortilin is essential for proNGF-induced neuronal cell death. Nature. 2004 : 427 : 843 8.
69. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD, Kermani P, Torkin R, Chen ZY, Lee FS, Kraemer RT, Nykjaer A, Hempstead BL. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci. 2005 : 25 : 5455 63.
70. Domeniconi M, Zampieri N, Spencer T, Hilaire M, Mellado W, Chao MV, Filbin, MT. MAG induces regulated intramem-brane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron. 2005 : 46 : 849 55.
71. NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin. FASEB J. 2006 : 20 : 1939 41.
72. Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci USA. 2005 : 102 : 1205 10.
73. Chivatakarn O, Kaneko S, He Z, Tessier-Lavigne M, Giger RJ. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors. J Neurosci. 2007 : 27 : 7117 24.
74. Liu H, Ng CE, Tang BL. Nogo-A expression in mouse central nervous system neurons. Neurosci Lett. 2002 : 328 : 257 60.
75. Kim JE, Liu B P, Park JH, Strittmatter SM. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron. 2004 : 44 : 439 51.
76. Bullard TA, Protack TL, Aguilar F, Bagwe S, Massey HT, Blaxall BC. Identification of Nogo as a novel indicator of heart failure. Physiol Genomics. 2008 : 32 : 182 9.